Prawo i regulacje · 09/11/2022

Final Rule Places Ganaxolone in Schedule V of Controlled Substances Act

The Drug Enforcement Administration has finalized a rule placing ganaxolone, a medication, in Schedule V of the Controlled Substances Act, maintaining its current classification without changes, following an interim rule published in June 2022.